Back
Aspen Pharmacare Holdings Ltd.

Aspen Pharmacare Holdings Ltd.

Location

Global

Company size

9167

Industry

Products
Products: Other products

Target

Aspen Pharmacare Holdings Ltd. commits to reduce its Scope 1 and 2 greenhouse gas emissions 50% and scope 3 greenhouse gas emissions 30% by 2030 from a 2020 base year.

Aspen Pharmacare Holdings Ltd. is a multinational pharmaceutical company based in South Africa. It operates in various regions, including Africa, Asia, Europe, and Latin America. The company has a diverse portfolio of products, including branded and generic pharmaceuticals, as well as consumer healthcare products.

Aspen Pharmacare has several prominent subsidiaries, including Aspen Global Incorporated, Aspen Australia, and Aspen Europe. These subsidiaries play a significant role in the company's operations and contribute to its global presence.

The company has a substantial employee count, with thousands of employees worldwide. Its top operational locations include South Africa, Australia, Germany, Brazil, and China. These regions serve as key hubs for Aspen Pharmacare's manufacturing, distribution, and research activities.

Target details
Base Year
2020
Near-term
Target details not available
Scope 1:
by
Scope 2:
by
Scope 3:
by
Long-term
Target details not available
Scope 1:
by
Scope 2:
by
Scope 3:
by
Net-Zero
2050
Visit their website for more information
0.0641670764
kgCO2e/
USD
Carbon intensity ratio by revenue
151263.00
MTCO2e
Total emissions
2357330402.00
USD
Annual revenue
Scope 1
40082.00
MTCO2e
Emissions data not available
Scope 2
Emissions data not available
111181.00
MTCO2e
Market-based:
MTCO2e
Location-based:
MTCO2e
Scope 3
MTCO2e
Emissions data not available
Emissions breakdown by GHGP scopes
C1: Purchased goods and services
MTCO2e
C2: Capital goods
MTCO2e
C3: Fuel- and energy-related activities not included in S1/S2
MTCO2e
C4: Upstream transportation & distribution
MTCO2e
C5: Waste generated in operations
MTCO2e
C6: Business travel
MTCO2e
C7: Employee commute
MTCO2e
C8: Upstream leased assets
MTCO2e
C9: Downstream transportation & distribution
MTCO2e
C10: Processing of sold products
MTCO2e
C11: Use of sold products
MTCO2e
C12: End-of-life treatment of sold products
MTCO2e
C13: Downstream leased assets
MTCO2e
C14: Franchises
MTCO2e
C15: Investments
MTCO2e
Uncategorised
MTCO2e
Scope 3 breakdown
Reduction strategies not yet available. Please check back later.
Case studies not yet available for this company. Please check back later.